392 trials
Anatomic Stage II Breast Cancer AJCC v8 · Anatomic Stage IIA Breast Cancer AJCC v8 · Anatomic Stage IIB Breast Cancer AJCC v8
Primary: Feasibility of Enrolling 15 Patients Within 2 Years — 8 Participants
Heart Failure
Primary: Blood Flow — 300; 275 ml/min
Ketamine · Lactation
Primary: Ketamine Concentration in Breast Milk, up to 12 Hours at 3 Hour Intervals, Following an IM Administration of .5mg/kg Ketamine — 51.2; 22.6; 10.6; 4.5 ng/mL
Endometrial Cancer
Primary: Percentage of Participants With Positive Predictive Value and Negative Predictive Value From Fluorescein Visualization — 71; 100; 85; 90 percentage of participants
Opioid-use Disorder
Primary: Recruitment Rate — 3; 12; 5 Participants
Fragile X Syndrome
Primary: Change in EEG Relative Gamma Power — 0.0024; -0.0077; -0.0039; 0.0019 percent of power in gamma frequencies
Healthy Volunteers · Alzheimer Disease · Molecular Imaging
Primary: Determination of the Regional Density and Distribution of I2BS in Healthy Human Brain (1TCM Model) — 44.5; 39.3; 62.7; 38.6 mL/cm^3
Wrinkle · Photoaging
Primary: Change in Wrinkle Appearance — 19.0; 23.2 percentage of reduced fine wrinkles
Pain, Postoperative
Primary: Cumulative Opioid Consumption: Postoperative Opioid Consumption, Oral Morphine Equivalents (mg) — 77; 51 oral morphine equivalents (mg) — p=0.092
Cortical Excitability · Psychiatric Disorder
Primary: The Change of Motor Cortex Excitability Measures by ppTMS — 0.059; 0.005; 0.073; -0.341 Ratio
HIV/AIDS · Sexually Transmitted Diseases
Primary: Uptake of HIV Self-testing Over the 3 Months Follow-up — 19; 7; 24; 4 Participants — p=<0.05
Cannabis-use Disorders
Primary: Number of Self-administered Puffs of Smoked Cannabis Containing Active THC Concentrations Compared to Placebo Under Controlled Laboratory Conditions — 2.00; 2.67; 3.60…
Nicotine Addiction
Primary: DEQ - Pleasurable — 2.14; 2.05; 1.98; 2.37 score on a scale
Pain
Primary: Number of Participants With Adverse Events Stratified by Overall and Severity — 7; 3; 2; 0 Participants
Lower Limb Injury
Primary: Analgesia Duration — 22.1; 25.7 Hours